STOCK TITAN

Qiagen NV - QGEN STOCK NEWS

Welcome to our dedicated news page for Qiagen NV (Ticker: QGEN), a resource for investors and traders seeking the latest updates and insights on Qiagen NV.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Qiagen NV's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Qiagen NV's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
covid-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.51%
Tags
fda approval
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.5%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
none
Qiagen NV

NYSE:QGEN

QGEN Rankings

QGEN Stock Data

9.52B
219.40M
0.42%
75.16%
1.49%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
Netherlands
Venlo

About QGEN

qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from blood, tissue and other materials. assay technologies make these biomolecules visible and ready for analysis. bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. automation solutions tie these together in seamless and cost-effective molecular testing workflows. qiagen provides these workflows to more than 500,000 customers around the world in molecular diagnostics (human healthcare), applied testing (forensics, veterinary testing and food safety), pharma (pharmaceutical and biotechnology companies) and academia (life sciences research). as of june 30, 2015, qiagen employed approximately 4,400 people in over 35 locations worldwide. further information can be found at http://www.qiagen.com.